OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
26
Results
Show all
Save search
Copy query
Show results for
Unknown
(26)
Publication Date
Release Date
2015
(10)
2018
(4)
2017
(3)
2014
(3)
2016
(2)
2026
(1)
2023
(1)
2021
(1)
2019
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Research Questions and Outcomes Prioritized by Patients With Dry Eye.
Not available
S-EPMC6218931
|
biostudies-literature
Cite
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.
Not available
S-EPMC5000843
|
biostudies-literature
Cite
Twelve-Month Clinical and Histopathological Performance of a Novel Synthetic Cornea Device in Rabbit Model.
Not available
S-EPMC10431210
|
biostudies-literature
Cite
Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.
Not available
S-EPMC4527886
|
biostudies-literature
Cite
Patient-Reported Symptoms Versus Clinician-Measured Signs to Distinguish Sjogren's in Patients With Dry Eye.
Not available
S-EPMC12849820
|
biostudies-literature
Cite
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report.
Not available
S-EPMC4506719
|
biostudies-literature
Cite
Inter-grader Agreement of the Ocular Staining Score in the Sjogren's International Clinical Collaborative Alliance (SICCA) Registry.
Not available
S-EPMC4651820
|
biostudies-literature
Cite
The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.
Not available
S-EPMC4465990
|
biostudies-literature
Cite
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time.
Not available
S-EPMC5871538
|
biostudies-literature
Cite
Combination immunotherapy after ASCT for multiple myeloma using MAGE-A3/Poly-ICLC immunizations followed by adoptive transfer of vaccine-primed and costimulated autologous T cells.
Not available
S-EPMC4557204
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets